33 related articles for article (PubMed ID: 436278)
1. Effect of hydroxylysine-O-glycosylation on the structure of type I collagen molecule: A computational study.
Tang M; Wang X; Gandhi NS; Foley BL; Burrage K; Woods RJ; Gu Y
Glycobiology; 2020 Sep; 30(10):830-843. PubMed ID: 32188979
[TBL] [Abstract][Full Text] [Related]
2. Biochemical markers of bone turnover in Paget's disease.
Russell RG; Beard DJ; Cameron EC; Douglas DL; Forrest AR; Guilland-Cumming D; Paterson AD; Poser J; Preston CJ; Milford-Ward A; Woodhead S; Kanis JA
Metab Bone Dis Relat Res; 1981; 3(4-5):255-62. PubMed ID: 6220191
[TBL] [Abstract][Full Text] [Related]
3. A high molecular weight protein extract of Mastobranchus indicus (Mi-64) having antiarthritic activity in experimental animals.
Alam MA; Sarkar SK; Gomes A
Inflammation; 2012 Aug; 35(4):1223-31. PubMed ID: 22327804
[TBL] [Abstract][Full Text] [Related]
4. Management of osteoporosis and Paget's disease. An appraisal of the risks and benefits of drug treatment.
Gennari C; Nuti R; Agnusdei D; Camporeale A; Martini G
Drug Saf; 1994 Sep; 11(3):179-95. PubMed ID: 7811400
[TBL] [Abstract][Full Text] [Related]
5. Measurement of the cross linking compound, pyridinoline, in urine as an index of collagen degradation in joint disease.
Robins SP; Stewart P; Astbury C; Bird HA
Ann Rheum Dis; 1986 Dec; 45(12):969-73. PubMed ID: 3813668
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture.
McLaren AM; Hordon LD; Bird HA; Robins SP
Ann Rheum Dis; 1992 May; 51(5):648-51. PubMed ID: 1616331
[TBL] [Abstract][Full Text] [Related]
7. Urine products of bone breakdown as markers of bone resorption and clinical usefulness of urinary hydroxyproline: an overview.
Simsek B; Karacaer O; Karaca I
Chin Med J (Engl); 2004 Feb; 117(2):291-5. PubMed ID: 14975218
[TBL] [Abstract][Full Text] [Related]
8. Skeletal metabolism in Paget's disease of bone.
Krane SM
Arthritis Rheum; 1980 Oct; 23(10):1087-94. PubMed ID: 7000079
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.
Krane SM; Kantrowitz FG; Byrne M; Pinnell SR; Singer FR
J Clin Invest; 1977 May; 59(5):819-27. PubMed ID: 404321
[TBL] [Abstract][Full Text] [Related]
10. The origin of urinary hydroxylysyl glycosides in Paget's disease of bone and in primary hyperparathyroidism.
Askenasi R; De Backer M; Devos A
Calcif Tissue Res; 1976 Nov; 22(1):35-40. PubMed ID: 1000341
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of glycosaminoglycans and hydroxyproline in Paget's disease of bone, compared with neoplastic invasion of bone.
Bower L; Manley G
J Clin Pathol; 1981 Oct; 34(10):1097-101. PubMed ID: 7309892
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of collagen metabolites in protein malnutrition.
Sambasiva Rao J; Rao VH
J Clin Chem Clin Biochem; 1980 May; 18(5):287-91. PubMed ID: 7430958
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of hydroxyproline and hydroxylysyl glycosides in adjuvant-induced arthritis.
Orloff S; Rao VH; Verbruggen L
Ital J Biochem; 1979; 28(3):173-82. PubMed ID: 553901
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of hydroxyproline, hydroxylysine and hydroxylysine glycosides by patients with Paget's disease of bone and carcinoma with metastases in bone.
Kelleher PC
Clin Chim Acta; 1979 Mar; 92(3):373-9. PubMed ID: 436278
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
